Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,819 INR | +0.74% | +5.53% | +9.48% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.48% | 2.78B | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-20.07% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B | |
+21.27% | 996M | |
-6.63% | 908M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Nomura Upgrades Dr. Lal PathLabs to Neutral From Reduce, Adjusts Price Target to INR1,864 From INR1,819